Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

TMCI.US Logo

TMCI.US - Current Price

$2.80

Company Information

Company Name
Treace Medical Concepts Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US89455T1097
CIK: 0001630627
CUSIP: 89455T109
Currency: USD
Full Time Employees: 477
Phone: 904 373 5940
Fiscal Year End: December
IPO Date: Apr 23, 2021
Description:

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible correction of metatarsus adductus deformities and osteoarthritis of the midfoot. It serves physicians, surgeons, ambulatory surgery centers and hospitals related to the surgical management of bunion and related midfoot deformities. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Address:

100 Palmetto Park Place, Ponte Vedra, FL, United States, 32081

Directors & Officers

Name Title Year Born
Mr. John T. Treace Founder, Chairman & CEO 1972
Mr. Mark L. Hair CPA Chief Financial Officer 1970
Mr. Scot M. Elder J.D. Chief Legal & Compliance Officer and Corporate Secretary 1975
Dr. Sean F. Scanlan Ph.D. Chief Innovation Officer 1982
Mr. Gaetano M. Guglielmino Chief Commercial Officer 1970
Mr. Terry W. Lubben Chief Operations & Supply Chain Officer 1965
Mr. Taylor Erickson Chief Information & Cybersecurity Officer NA
Mr. Brad Barr Senior Vice President of Sales NA
Mr. Daniel E. Owens Chief Human Resources Officer 1972
Ms. Shana Zink Senior Vice President of Clinical Affairs & Reimbursement NA

Shares Statistics

Shares Outstanding: 63.72M
Shares Float: 47.68M
% Insiders: 2,535.60%
% Institutions: 6,121.60%
Short % Float: 6.54%

Valuation Metrics

Enterprise Value: $191.37M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $178.41M
EBITDA: $-39.33M
Book Value: $1.40
Earnings/Share: $-0.80
Profit Margin: -22.89%
Operating Margin: -29.23%
ROA (TTM): -14.77%
ROE (TTM): -51.63%
Revenue (TTM): $218.88M
Revenue/Share (TTM): $3.48
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 11.40%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

Date EPS Actual EPS Estimate Difference Surprise %
Mar 31, 2026 0.00 -0.23 N/A 10,000.00%
Dec 31, 2025 0.00 -0.15 N/A 10,000.00%
Sep 30, 2025 -0.26 -0.28 N/A 714.29%
Jun 30, 2025 -0.28 -0.29 N/A 344.83%
Mar 31, 2025 -0.25 -0.30 N/A 1,833.22%
Dec 31, 2024 0.00 -0.04 N/A 9,625.29%
Sep 30, 2024 -0.25 -0.27 N/A 740.74%
Jun 30, 2024 -0.29 -0.29 N/A 0.00%
Mar 31, 2024 -0.30 -0.30 N/A 0.00%
Dec 31, 2023 -0.10 -0.09 N/A -1,111.11%
Sep 30, 2023 -0.28 -0.26 N/A -769.23%
Jun 30, 2023 -0.20 -0.24 N/A 1,666.67%
Mar 31, 2023 -0.23 -0.23 N/A 0.00%
Dec 31, 2022 -0.08 -0.14 N/A 4,285.71%
Sep 30, 2022 -0.22 -0.29 N/A 2,413.79%
Jun 30, 2022 -0.31 -0.20 N/A -5,500.00%
Mar 31, 2022 -0.16 -0.20 N/A 2,000.00%
Dec 31, 2021 -0.12 -0.01 N/A -196,896.55%
Sep 30, 2021 -0.12 -0.12 N/A 0.00%
Jun 30, 2021 -0.10 -0.12 N/A 1,666.67%
Mar 31, 2021 -0.07 -0.06 N/A -1,666.67%
Dec 31, 2020 -0.10 0.00 N/A N/A
Dec 31, 2019 -0.05 0.00 N/A N/A

Balance Sheet (Yearly)

Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $11.35M $N/A $217.09M $104.20M $112.89M
2023-12-31 $12.98M $N/A $251.91M $113.97M $137.94M
2022-12-31 $19.47M $N/A $159.02M $98.50M $60.53M
2021-12-31 $105.83M $N/A $140.82M $47.75M $93.07M
2020-12-31 $18.08M $N/A $41.81M $41.03M $776.00K
2019-12-31 $12.14M $N/A $29.72M $26.56M $3.16M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 17, 2025 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist